Indexing metadata

Comparison between the Improvements in Disease Activity Score 28 (DAS28) Using Erythrocyte Sedimentation Rate (DAS28-ESR) and Clinical Parameters in Cases of Waja-al-Mafasil (Rheumatoid Arthritis)


 
Dublin Core PKP Metadata Items Metadata for this Document
 
1. Title Title of document Comparison between the Improvements in Disease Activity Score 28 (DAS28) Using Erythrocyte Sedimentation Rate (DAS28-ESR) and Clinical Parameters in Cases of Waja-al-Mafasil (Rheumatoid Arthritis)
 
2. Creator Author's name, affiliation, country Mohd. Wasim Ahmad; Research Officer (U), Scientist L-1, Drug Standardization Research Institute (DSRI), Ghaziabad, under CCRUM, Ministry of Ayush, India
 
2. Creator Author's name, affiliation, country Anirban Goswami; Investigator (Statistics), Regional Research Institute of Unani Medicine, Patna, under CCRUM, Ministry of Ayush, India
 
2. Creator Author's name, affiliation, country Rajesh .; Research Officer (U), Scientist L-1, Regional Research Institute of Unani Medicine, Patna, under CCRUM, Ministry of Ayush, India
 
2. Creator Author's name, affiliation, country Md. Ishtiyaque Alam; Research Officer (U), Scientist L-4, Regional Research Institute of Unani Medicine, Patna, under CCRUM, Ministry of Ayush, India
 
2. Creator Author's name, affiliation, country (doi: 10.23953/cloud.ijaayush.345)
 
3. Subject Discipline(s)
 
3. Subject Keyword(s) Clinical Parameters; Disease Activity Score 28 (DAS-28); Improvement; Rheumatoid Arthritis (RA)
 
4. Description Abstract

Waja-al-Mafasil (Rheumatoid Arthritis) is a progressive, disabling, chronic multisystem disease of unknown cause characterized by pain, swelling and stiffness of synovial joints. The Disease Activity Score (DAS) is a major scoring system for evaluating disease activity of Waja-al-Mafasil (Rheumatoid Arthritis). DAS28 was originally using the erythrocyte sedimentation rate (ESR) as the inflammation marker and named DAS28-ESR. The aim of this study to compare the improvement in disease activity score 28 using erythrocyte sedimentation rate (DAS28-ESR) and clinical parameters in the patients of Rheumatoid Arthritis. Rheumatoid Arthritis patients registered in research OPD was used to calculate DAS28-ESR and clinical assessment. In this study, Majun Jograj Gugal (Semisolid) and Raughan-e-Malkangani (Oil) were administrated to patients for the period of twelve weeks. Improvements of DAS28-ESR were also evaluated according to the European League against Rheumatism response criteria and percentage improvement of clinical parameters in Rheumatoid Arthritis patients. Improvements in DAS28-ESR and Clinical Parameters criteria were compared by Woolf statistical test, Cohen's Kappa (𝜅) statistic for agreement and linear regression analysis. Classification of improvement in DAS28-ESR and clinical parameters among on the demographical characteristics and RA-Factor were generally identical (p-value >0.05) except patients’ nature of work (p-value <0.05). Simple linear regression analysis showed a significant correlation between improvement between DAS28-ESR and clinical parameters (R2 = 0.64; p-value <0.001). The Cohen's Kappa (𝜅) coefficient (95% CI) between of them was 0.43 (0.21 to 0.66), indicating good agreement (p-value <0.001). This study concluded that improvements in Disease Activity Score 28 (DAS28) using erythrocyte sedimentation rate (DAS28-ESR) and Clinical Parameters are same in cases of Rheumatoid Arthritis.


 
5. Publisher Organizing agency, location
 
6. Contributor Sponsor(s)
 
7. Date (YYYY-MM-DD) 2018-04-07
 
8. Type Status & genre Peer-reviewed Article
 
8. Type Type
 
9. Format File format PDF
 
10. Identifier Uniform Resource Identifier http://medical.cloud-journals.com/index.php/IJAAYUSH/article/view/417
11. Source Journal/conference title; vol., no. (year) International Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy; Vol 7, No 1 (2018)
 
12. Language English=en en
 
14. Coverage Geo-spatial location, chronological period, research sample (gender, age, etc.)
 
15. Rights Copyright and permissions

Copyright Terms & Conditions

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work

Cloud Publications reserves the right to amend/change the copyright policy; with/without notice.